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Background: Myc is an oncogenic transcription factor that is frequently deregulated in cancer, and Sin3b is a transcriptional
regulator that recruits histone deacetylases.
Results: A new interaction between the protein Sin3b and Myc that leads to Myc down-regulation is described.
Conclusion: Sin3b-Myc interaction regulates Myc levels and activity.
Significance: Sin3b adds a second level of control of Myc by directly regulating Myc levels.
Myc expression is deregulated in many human cancers. A yeast
two-hybrid screen has revealed that the transcriptional repressor
Sin3b interacts with Myc protein. Endogenous Myc and Sin3b co-
localize and interact in the nuclei of human and rat cells, as assessed
by co-immunoprecipitation, immunofluorescence, and proxim-
ity ligation assay. The interaction is Max-independent. A
conserved Myc region (amino acids 186 –203) is required for
the interaction with Sin3 proteins. Histone deacetylase 1 is
recruited to Myc-Sin3b complexes, and its deacetylase activ-
ity is required for the effects of Sin3b on Myc. Myc and
Sin3a/b co-occupied many sites on the chromatin of human
leukemia cells, although the presence of Sin3 was not associ-
ated with gene down-regulation. In leukemia cells and fibro-
blasts, Sin3b silencing led to Myc up-regulation, whereas
Sin3b overexpression induced Myc deacetylation and degra-
dation. An analysis of Sin3b expression in breast tumors
revealed an association between low Sin3b expression and
disease progression. The data suggest that Sin3b decreases
Myc protein levels upon Myc deacetylation. As Sin3b is also required
for transcriptional repression by Mxd-Max complexes, our results
suggest that, at least in some cell types, Sin3b limits Myc activity
through two complementary activities: Mxd-dependent gene repres-
sion and reduction of Myc levels.
c-Myc (hereafter Myc) is an oncogenic transcription factor of
the helix-loop-helix/leucine zipper protein family. Myc forms
heterodimers with the protein Max, which bind to DNA
sequences called E-boxes (1–3). Myc-Max regulates thousands
of genes and binds to about 15% of genomic loci. Most target
genes are activated by Myc in an E-box-dependent manner,
although an important fraction of Myc target genes are
repressed (4 –7). Recent developments suggest that Myc func-
tions as an amplifier of active genes (8, 9) Myc activates tran-
scription by recruiting a multiprotein complex that includes
histone acetyltransferases (2, 10, 11). In agreement with its large
number of target genes, Myc exerts a wide array of biological
functions including cell cycle control, genomic instability, ener-
getic metabolism, protein synthesis, intercellular communica-
tion, and control of cell differentiation (1, 10, 12, 13). Myc is
deregulated in about half of human tumors and frequently
appears to be associated with tumor progression (14 –16).
Myc transcriptional activity is also controlled by several
competing repressive Max-binding partners of the Mxd family
(Mxd1, Mxi1, Mxd3, Mxd4, and Mnt). Mxd-Max dimers are
biochemical antagonists of Myc-Max, i.e. they repress gene
expression upon binding to E-boxes in the regulatory regions of
the target genes (17, 18). Mxd-Max heterodimers repress tran-
scription by recruiting Sin3a and Sin3b. Sin3 originally was dis-
covered in yeasts as an essential component of transcriptional
regulatory complexes containing multiple components (19, 20).
Mammalian Sin3 proteins were discovered as interactors of
Mxd proteins, which carry a conserved Sin3-interacting
domain (SID) in their N-terminal region (21–24). Sin3-Mxd
interaction takes place through the paired amphipathic helices
(PAH)5 of the Sin3a/b C-terminal region and is required for the
transcriptional repression exerted by Mxd proteins on their
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target genes (22, 25–27). The mechanism through which Sin3b
represses transcription involves the recruitment of histone
deacetylases (HDACs) types 1 and 2 (28 –30). Sin3-containing
complexes, besides HDAC1 and HDAC2, contain other pro-
teins to form a transcription regulatory complex (reviewed in
Refs.19, 29, and 31). Compared with Sin3a interactions, much
less is known about Sin3b interactions. There are differences in
the protein interactions described for each Sin3 family member
(32–35) and the phenotypes of Sin3a- and Sin3b-deficient mice,
with the Sin3a knock-out mice showing an earlier lethality than
Sin3b knock-out mice (35). Here we show an interaction
between Myc and Sin3b that results in impaired Myc transcrip-
tional activity. The Myc region involved in the interaction is a
small conserved region (Myc box III). Myc-Sin3b interaction
leads to Myc deacetylation and destabilization, and co-expres-
sion of Sin3b leads to reduced Myc levels.
EXPERIMENTAL PROCEDURES
Breast Tumor Samples and Immunohistochemical Analysis—
A total of 106 infiltrating ductal breast carcinoma tumors from
the archive of the Pathology Department of the M. D. Anderson
Cancer Center (Madrid, Spain) were studied. All of the tumors
were grade 3. Patients underwent surgery between 2006 and
2007. The mean patient age at surgery was 57.8 years (range, 33
to 82 years). According to the TNM (tumor-node-metastasis)
classification for staging, 32 of the tumors were stage I, 35 were
stage II, and 34 were stage III–IV. Among the tumors, 17.5%
developed metastasis. Histological and immunohistochemical
studies were all carried out on formalin-fixed, paraffin-embed-
ded tissue samples. The standard ethical procedures of the
Spanish regulation (Ley de Investigación Biomédica) were fol-
lowed. All participants in this study signed informed consent
forms, and the study was approved by the Institutional Review
Boards and the bioethics committee of the M. D. Anderson
Cancer Center (Madrid, Spain). Sin3b immunohistochemical
staining was performed by the labeled streptavidin-biotin
(EnVisionTM kits, Dako) method with a heat-induced antigen
retrieval step. Briefly, sections were immersed in boiling 10 mM
sodium citrate, pH 6.0, for 3 min in a pressure cooker. A poly-
clonal antibody against human Sin3b was used. The antibodies
used are listed in Table 1. The primary antibodies were omitted
in the negative controls. Sin3b staining was scored as positive
when nuclear localization was observed in at least 10% of the
tumor cells and as negative when expressed in less than 10% of
the tumor cells. For the meta-analysis of breast cancer and
Sin3b correlation, the breast microarray and clinical data were
obtained from the International Cancer Research (ICR) data-
base. The statistical survival analysis of breast samples was per-
formed using ROCK and SPSS software. Kaplan-Meier plots
were used to estimate the overall survival curves using log-rank
tests. The expression value of Sin3b was categorized using the
upper quartile (25%) against the rest. The chi-square contin-
gency test with Yates’ correction or a Fisher’s exact test was
used to determine the statistical significance of the relation-
ships between SIN3B expression and survival or metastasis.
Values of p  0.05 were considered statistically significant.
These analyses were carried out using the SPSS 17.0 software.
Yeast Two-hybrid Screening—The Matchmaker system 3
(Clontech) was used for the yeast two-hybrid screen. The bait
protein consisted of the full-length human Myc protein sub-
cloned in the pGBKT7 vector (containing a GAL4 DNA-bind-
ing domain). A pACT2 vector-based mouse NIH3T3 fibroblast
cDNA library (Mouse Embryonic Fibroblast Matchmaker,
Clontech) was used to screen for prey proteins. Yeasts (AH109
strain) were transformed with the EasyComp transformation
kit for Saccharomyces cerevisiae (Invitrogen). Positive colonies
were isolated based on their capacity to express the markers
ADE2 and HIS3, which allowed them to grow on SC AHLW,
a selection medium lacking tryptophan, leucine (selection
markers for pGBKT7 and pACT2 plasmids, respectively), ade-
nine, and histidine. pTD1 and pVA3 plasmids (Clontech) were
used as an interaction positive control in the yeast two-hybrid
system. The pLAM5 plasmid (Clontech) was used as a control
to detect fortuitous protein-protein interactions. pACT2-Myc
vector consisted of full-length human Myc subcloned in the
pACT2 vector, which encodes for the GAL4 transactivation
domain. The clones were also grown in SC LW medium,
which lacks tryptophan and leucine (the selection markers
for pGBKT7- and pACT2-based plasmids, respectively), to
rule out the possibility that the absence of growth in the
selection medium SC AHLW was not due to an inefficient
transformation.
Cell Culture and Transfections—HEK293T and K562 cells were
from ATCC. K562/S is a K562 subclone able to grow attached to
plastic (36). The P493-6 cell line consists of immortalized human B
cells carrying a tetracycline-repressible Myc transgene (37). K562
cells and derivatives were grown in RPMI medium (Invitrogen)
supplemented with 10% fetal bovine serum (Lonza), 100 units/ml
penicillin, and 100 g/ml streptomycin. Rat1a cells were a gift
from Chi Dang (University of Pennsylvania) (38). Rat1aMyc was
generated by transfection of Rat1a cells with pCEFL-Myc (36) and
selection with 0.4 mg/ml G418 (Sigma). UR61 cells derive from rat
pheochromocytoma (39). Rat1a and UR61 cells were cultured
in DMEM (Invitrogen) supplemented with serum and anti-
biotics as described above. The vectors used were as follows:
pME18S-Myc-FLAG, pME18S-MycD1–98-FLAG, pME18S-
MycD106–143-FLAG, pME18S-MycD157–262-FLAG, pME18S-
MycD186 –203-FLAG, pME18S-MycD244 –271-FLAG, and
pME18S-MycD348 – 439-FLAG (39). pcDNA3-Myc-HA was
constructed in this work, using the Myc cDNA from pCEFL-
Myc (36). pcDNA3-Sin3b-FLAG and pcDNA3-Sin3b-HA were
constructed from pcDNA3-Sin3b, encoding full-length murine
Sin3b cDNA (a gift from Gregory David, New York University
Medical Center, NY). Other vectors used for transfections
were: pcDNA3-HDAC1-FLAG, pcDNA3-HDAC2-FLAG, and
pSC2-Sin3a-myc (22) and the corresponding empty vectors
pME18S, pcDNA3, pCEFL, and pSC2. For transient transfec-
tion of HEK293T cells for protein immunoprecipitation and
immunoblot analysis, typically 750,000 cells were transfected
using FuGENE 6 transfection reagent (Roche Applied Science)
following the manufacturer’s instructions and were lysed 24 h
after transfection. In order to silence Sin3b expression in
Rat1aMyc cells and in K562 cells, two siRNA duplexes (Mission
siRNA, Sigma-Aldrich, 100 pmol each; RNA sequences avail-
able upon request) were transfected to each cell line by using
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Lipofectamine 2000 (Invitrogen) for Rat1aMyc and by electro-
poration in an Amaxa electroporator for K562 cells. Sin3b RNA
levels were analyzed 24 h after transfection. K562 cells were
transiently transfected with 5 g of pcDNA3-Sin3bHA plas-
mid or empty pCDNA3 vector. When indicated, the cells
were treated with 12-O-tetradecanoylphorbol-13-acetate
(TPA, Sigma), trichostatin A (TSA, Sigma), and vorinostat
(from LC Biochemicals).
Protein Analysis—Cells were lysed using cold lysis buffer
consisting of 1% IGEPAL (Sigma-Aldrich), 150 mM NaCl, 50
mM Tris, pH 8, and 1 mM EDTA, pH 8, and the following pro-
tease and phosphatase inhibitors: aprotinin (20 g/ml), leupep-
tin (2 g/ml), PMSF (2 mM), sodium orthovanadate (1 mM),
sodium fluoride (5 mM) and -glycerol phosphate (5 mM). The
protein concentration was determined using the BCA assay
(Thermo Scientific). For protein immunoprecipitation, typi-
cally 300 g of protein was immunoprecipitated with 1 g of
the corresponding antibody using protein G-coupled Dyna-
beads magnetic beads (Dynal, Invitrogen). Mouse IgG was from
Jackson ImmunoResearch Laboratories. For immunoblotting,
the entire immunoprecipitated fraction (for co-immunopre-
cipitation analysis) or 50 g of protein (for expression analysis)
was electrophoresed in SDS-PAGE (acrylamide percentage
ranging from 7.5 to 10%) and transferred onto PVDF or nitro-
cellulose membranes (Millipore) by standard procedures. The
primary antibodies used are shown in Table 1. Immunoblots
were revealed with an enhanced chemiluminescence system
(GE Healthcare) or with the Odyssey scanner (LI-COR
Biosciences).
RNA Analysis—Total RNA was isolated using the RNeasy
mini kit (Qiagen). cDNAs preparation by reverse transcription
and quantitative polymerase chain reaction (RT-qPCR) was
performed as described previously (40). The primers for the
assayed genes are shown in Table 2. The expression of the ana-
lyzed genes was normalized against the -actin mRNA levels.
Pull-down Assay—For the pull-down assay, DH5 cells
(Invitrogen) were transformed with pGEX-Myc-GST (glutathi-
one S-transferase) plasmid (41) and grown to exponential phase
at 37 °C until an A600 nm of 0.6 – 0.8 was reached. Myc-GST
expression was induced with 0.5 mM IPTG for 3 h at 37 °C. The
cell pellet was resuspended in BFX buffer (20 mM Tris, pH 7.4, 1
M NaCl, 0.2 mM EDTA, 1% Triton X-100, and protease-phos-
phatase inhibitors) and sonicated. After centrifugation (13,000
rpm for 30 min), the supernatant was collected and incubated
for 1 h at 4 °C with glutathione-Sepharose 4B beads (GE Health-
care) equilibrated previously with PBS and BFX buffer. Beads
were washed with GST-FISH buffer (10% glycerol, 50 mM Tris,
pH 7.4, 100 mM NaCl, 1% Nonidet P-40, and 2 mM MgCl2) and
TABLE 1
Primary antibodies used
Use in immunoblot (IB), immunofluorescence (IF), immunoprecipitation (IP), proximity ligase assay (PLA), immunohistochemistry (IHQ), and chromatin immunopre-
cipitation (ChIP) experiments is indicated. The dilution of the antibodies used for immunoblot was 1:1000.
Antigen Type Source Reference no. Use (dilution)
Acetyl-lysine Mouse monoclonal Cell Signaling Technology 9681 IB
Actin Goat polyclonal Santa Cruz Biotechnology I-19, sc-1616 IB
FLAG Mouse monoclonal Sigma-Aldrich F3165 IB, IP
GST Rabbit polyclonal Sigma-Aldrich G7781 IB
HDAC1 Rabbit polyclonal Abcam Ab19845 IB
HA Rat monoclonal Roche Applied Science 3F10 IB, IP
Max Rabbit polyclonal Santa Cruz Biotechnology C124, sc-765 PLA (1:100)
Mxd1 Rabbit polyclonal Santa Cruz Biotechnology C19, sc-222 PLA (1:100)
Myc Mouse monoclonal Santa Cruz Biotechnology C33, sc-42 PLA (1:25) IB
Mouse monoclonal Santa Cruz Biotechnology 9E10, sc-40 IB
Mouse Monoclonal Neomarkers Ab5, MS-1054 IB
Rabbit polyclonal Santa Cruz Biotechnology N-262, sc-764 IB, IP, ChIP
IF (1:100)
PLA (1:50)
Kat2A Goat polyclonal Santa Cruz Biotechnology N-18, sc-6303 IB
Phospho-H3 (Ser-10) Rabbit polyclonal Santa Cruz Biotechnology sc-8656 IB
Sin3b Rabbit polyclonal Santa Cruz Biotechnology A20, sc-996 IB, IP, ChIP
IF (1:200)
IHQ (1:100)
PLA (1:100)
Mouse monoclonal Santa Cruz Biotechnology H4, sc-13145 IB
-Tubulin Rabbit polyclonal Santa Cruz Biotechnology H-300, sc-5546 IB
TABLE 2
Sequences of the PCR primers used
The forward primer is listed first, and the reverse primer is listed second. All primers were used at 0.3 M.
Gene (species) Primer sequences 53 3 Used for
-Actin (human) AAATCTGGCACCACACCTTC and TAGCACAGCCTGGATAGCAA RT-qPCR
CAD (human) CCGCAGTCTCTGCTGCTG and ACCCGTCCTCCAACACTAGG ChIP
CDK4 (human) CTGACCGGGAGATCAAGGTA and GGCTTCAGATCTCGGTGAAC RT-qPCR
AGGCATGTGTCATGTGTGATCTT and CCGCTCCCAGTCTTCCTTG ChIP
HES1 (human) CGGACATTCTGGAAATGACA and GTGCGCACCTCGGTATTAAC RT-qPCR
GGCAATAAAACATCCTGGCAC and TCATCCGTAGGCTTTAGGTTCTG ChIP
LDHA (human) TCCTGACTCAGGCTCATG and AGACAACCGACCGGCAGA ChIP
MYC (human) AAGACTCCAGCGCCTTCTCT and GTTTTCCAACTCCGGGATCT RT-qPCR
RPS14 (human) CAAGGGGAAGGAAAAGAAGG and GAGGACTCATCTCGGTCAGC RT-qPCR
SIN3B (rat) CATCCAGTCACCTCTGAGCA and GATCTCAGGGTGGTCCAGAA RT-qPCR
SRD5A1 (human) AAAGCCTATGCCACTGTTGG and ACATGCCCGTTAACCACAAG RT-qPCR
GAAACCAAGGCCCCACGT and TGCGCTTTGGGCTTATTCC ChIP
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incubated for 2 h at 4 °C with a protein extract obtained from
HEK293T cells transfected with pcDNA3-Sin3b-HA (and the
corresponding pcDNA3 vector) 24 h earlier. After four washes
with GST-FISH buffer, the proteins were collected and ana-
lyzed by immunoblotting. For the GST-Sin3b and recombinant
Myc pull-down assay, the first 1170 nucleotides (390 amino
acids) of murine Sin3b cDNA were subcloned into pGEX-4T
vector (GE Healthcare). This region encompasses the first three
PAH domains at the N terminus of the protein (NSin3b). To
this end, pcDNA3-Sin3b was digested with BamHI and the
resultant fragment subcloned in the pGEX-4T vector, generat-
ing the pGEX-4T-Sin3b plasmid. Myc recombinant protein
was purchased from OriGene. DH5 cells (Invitrogen) were
transformed with pGEX-4T-Sin3b (and the corresponding
empty vector) and grown to exponential phase at 37 °C until an
A600 nm of 0.6 – 0.8 was reached. GST-Sin3b expression was
induced with 0.5 mM IPTG for 3 h at 37 °C. The cell pellet was
resuspended in BFX buffer and sonicated. After centrifugation
(13,000 rpm for 30 min), the supernatant was collected and
incubated for 1 h at 4 °C with Pierce glutathione magnetic beads
(Thermo Scientific), previously equilibrated with binding/wash
buffer (125 mM Tris, pH 8, and 150 mM NaCl). Beads were
washed with binding/wash buffer and incubated for 2 h at 4 °C
with 50 ng of Myc recombinant protein. After three washes
with binding/wash buffer, the beads were resuspended in West-
ern blot loading buffer (containing SDS and -mercaptoetha-
nol) and boiled at 95 °C for 5 min, and the supernatant fractions
(containing the proteins) were collected and analyzed by
immunoblotting.
Luciferase Reporter Assays—The luciferase reporters used
were as follows: pGL3-E-box, carrying four E-box elements in
the pGL3 vector; and pGL3-E-BoxMut, carrying four mutated
E-boxes (42). Cells were transfected using FuGENE 6 transfec-
tion reagent (Roche Applied Science) with 30 ng of the reporter
vector, 3 ng of the pCMV vector (Clontech) encoding -
galactosidase (Clontech), and a total amount of 200 ng of the
indicated expression vectors. Twenty-four hours after transfec-
tion, cells were lysed and luciferase activity measured with the
luciferase assay substrate from the Dual-Luciferase reporter
assay system (Promega). The activity of firefly luciferase was
normalized to that of -galactosidase used as an internal con-
trol. To this end, -galactosidase activity was measured using
the Beta-Glo assay system (Promega). For treatment with the
HDAC inhibitors, cells transfected with the reporter and
expression vectors were treated 24 h after transfection with 300
nM TSA or 5 M vorinostat for another 24 h after luciferase
activity was measured. The statistical significance of the differ-
ences between luciferase values was based on p values calcu-
lated using the Student’s t test.
Immunofluorescence and in Situ Proximity Ligation Assay
(isPLA)—For immunofluorescence experiments, K562/S cells
were grown on coverslips and treated with 20 nM TPA (Sigma)
when indicated. Twenty-four hours after treatment, the cells
were fixed for 15 min in 3.7% paraformaldehyde in PBS. Then
the cells were permeabilized with 0.5% Triton X-100 for 30 min,
blocked for 30 min at 37 °C in 3% BSA/PBS/0.01Triton X-100,
incubated with primary antibodies overnight at 4 °C, washed in
PBS, and incubated with secondary antibodies. Subsequently,
samples were blocked in rabbit serum (Santa Cruz Biotechnol-
ogy, sc-2338) for 1 h and incubated again with primary and
secondary antibodies. After several washes, the cells were
mounted in mounting medium with DAPI (Invitrogen). The
primary antibodies are listed in Table 1. The secondary anti-
bodies were donkey anti-rabbit 488 and goat anti-rabbit 555
(Alexa Fluor, both diluted at 1:500). For isPLA we essentially
followed the technique already described (43). K562/S cells
grown on coverslips were treated with TPA, fixed, and permea-
bilized as above. The cells were incubated with blocking solu-
tion for 2 h at 37 °C and then incubated with primary antibodies
dissolved in blocking buffer (100 mM L-cysteine, 0.1 g/ml
salmon sperm DNA, 0.5 M EDTA, 0.05% Tween 20, 30 and
g/ml BSA in PBS) for 16 h at 4 °C. For each interaction a pair of
mouse and rabbit primary antibodies was used. The antibodies
and dilutions are listed in Table 1. To assay the Myc-Sin3b
interaction, we used anti-Myc rabbit polyclonal antibody and
anti-Sin3b mouse monoclonal antibody. To detect the primary
antibodies, secondary proximity probes binding rabbit and
mouse immunoglobulin (PLA probe anti-rabbit PLUS and
PLA probe anti-mouse MINUS, Olink Bioscience) were diluted
at 1:15 and 1:5, respectively, in blocking solution. The slides
were incubated with this proximity probe solution for 1 h at
37 °C, washed three times in 50 mM Tris, pH 7.6, 150 mM NaCl,
and 0.05% Tween-20 (TBS-T), and incubated with hybridiza-
tion solution containing connector oligonucleotides (Olink
Bioscience) for 45 min at 37 °C. Then the samples were washed
with TBS-T and subsequently incubated in the ligation solution
for 45 min at 37 °C. The ligation solution contained T4 DNA
ligase (Fermentas), allowing the ligation of secondary proximity
probes and connector oligonucleotides to form a circular DNA
strand. Subsequently, the samples were washed in TBS-T, incu-
bated with the amplification solution containing phi29 DNA
polymerase (Fermentas) for the roller cycle amplification for 90
min at 37 °C, and washed three times with TBS-T. Finally, the
samples were incubated with detection mix solution (contain-
ing Texas Red-labeled detection probes that recognize the
amplified product; Olink Bioscience) for 1 h at 37 °C, washed
twice in SSC-T buffer (150 mM NaCl, 15 mM sodium citrate, and
0.05% Tween 20, pH 7) and ethanol, and then mounted. Fluo-
rescence signals were detected by laser-scanning microscopy
(Axiovert 200M, Zeiss) and analyzed with AxioVision software
(Zeiss). isPLA-positive signals were quantified using ImageJ
software. At least 200 nuclei were measured for each experi-
mental condition.
Chromatin Immunoprecipitation (ChIP)—Cells were fixed
with 1% formaldehyde for 10 min at room temperature, and
fixation was stopped by incubation with 0.12 M glycine for 10
min at room temperature. The cells were washed with PBS and
lysed in 1% SDS lysis buffer. Cross-linked chromatin was frag-
mented by sonication to an average size of 500 bp and immu-
noprecipitated (500,000 cells/antibody). Antibodies and cell
lysates were incubated overnight at 4 °C and then for 4 h at 4 °C
with protein G-coupled magnetic beads (Dynabeads, Invitro-
gen) blocked with salmon sperm DNA (1 h at 4 °C). The pro-
tein-DNA cross-link was reversed in elution buffer (1% SDS and
0.1 M NaHCO3) and RNase overnight at 65 °C. The eluted mate-
rial was treated with proteinase K for 3 h at 45 °C, and the DNA
Sin3b Interacts with Myc and Decreases Myc Levels
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was purified using the QIAquick PCR purification kit (Qiagen).
Quantitative PCR (SYBR Green PCR kit, Bio-Rad) was per-
formed in a Bio-Rad iCycler iQ5 apparatus. The immunopre-
cipitations were carried out with anti-Myc and anti-Sin3b anti-
bodies or nonimmune rabbit IgG as a negative control (Table
1). The signals were normalized to the inputs and the signals
obtained with the non-immune rabbit IgG immunoprecipita-
tion. The re-ChIP assays were performed as described above
until reversion of protein-DNA cross-links. Magnetic beads
were eluted by using SDS elution buffer with 10 mM DTT for 1 h
at 37 °C. Half of the anti-Myc-immunoprecipitated chromatin
was then incubated with anti-Sin3B (A-20, Santa Cruz Biotech-
nology.) antibody; the other half was incubated with non-im-
mune IgG (Santa Cruz Biotechnology) as a control overnight at
4 °C. The subsequent steps were carried out as described above.
The data are the mean values  S.E. of two independent exper-
iments. The primers are listed in Table 2.
Genome-wide Chip-seq Analysis—DNA binding sites for
Sin3a and Max proteins in the K562 cell line identified by the
ENCODE/HAIB project were downloaded from the University
of California, Santa Cruz (UCSC), database. Similarly, DNA
binding sites for the c-Myc protein in K562 and GM12878 cell
lines identified by the ENCODE/Open Chrom project (release
of September 2012) were downloaded from the UCSC database.
In order to restrict the analysis to only bona fide binding sites, in
the case of Sin3a and Max, only those binding sites present in
both technical replicates were used. In the case of Myc, binding
sites from two human hematopoietic cell lines (K562 and
GM12878) were compared and the analysis was restricted to
the common binding sites. To detect those binding sites pres-
ent in gene promoters, gene information from the RefSeq data-
base was downloaded from the UCSC database (GRCh37/hg19
RefSeq release 55), and information 1 kb upstream and down-
stream of the transcription starting site for each gene (as anno-
FIGURE 1. Sin3b and Myc interact. A, interaction between Myc and Sin3b detected in two-hybrid screen. S. cerevisiae AH109 yeast was transformed with
expression vectors, indicated at the right, and plated on selection media SC LW and SC AHLW as indicated. The left panel shows the positive and Myc
controls, indicating that Myc does not allow growth in the restriction medium by itself. The right panel shows the growth due to the interaction of Myc with the
protein encoded by clone M168. The region of Sin3b protein encoded by the M168 clone is shown at the bottom. The right panel also shows that Myc does not
interact with lamin C, a control used to detect fortuitous or unspecific protein interactions. B, co-immunoprecipitation (IP) of Myc and Sin3b in HEK293T cells.
The cells were transfected with vectors for Myc-HA and Sin3b-FLAG, and after transfection, the lysates were immunoprecipitated with anti-FLAG to detect
Sin3b-bound proteins. The immunoprecipitates were analyzed by immunoblotting with anti-FLAG and anti-HA antibodies as indicated. Immunoprecipitations
with immunoglobulin G were conducted as a negative control (not shown). C, the cells were transfected with vectors encoding Myc-FLAG and Sin3b-HA, and
after transfection, the lysates were immunoprecipitated with anti-FLAG to detect Myc-bound proteins. The immunoprecipitates were analyzed by Western
blotting as in B. D, cellular Sin3b binds to recombinant Myc. Bacterially expressed Myc-GST was mixed with lysates of HEK293T cells transfected with
pCDNA3-Sin3b-HA or empty vector (EV). Myc-GST was incubated with glutathione-Sepharose, and the pulled down material was analyzed by immunoblotting
with the indicated antibodies. Sin3b expression in the input lysates is shown at the right. E, recombinant Sin3b and Myc proteins interact in vitro. A fusion
protein consisting of GST and the N-terminal domain of murine Sin3b (first 390 amino acids (NSin3b)) and Myc purified protein were incubated with glutathione
bound to magnetic beads. The levels of Myc, GST-NSin3b, and GST were determined in the inputs and in the pulled down material by immunoblotting.
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tated in the UCSC browser) was extracted. All downloaded files
were homogenized to bed format using perl and awk scripts
written in-house (available upon request). Finally, all compari-
sons between the number of binding sites of different proteins
were performed using the intersectBed tool from the BedTools
suite (44). A minimum of 10% of sequence overlap between
different binding sites was required. The normalization of bind-
ing sites/Mb was estimated considering 51.3 Mb of total pro-
moter sequence (according to RefSeq) and 3 Gb of total
genomic sequence. RNA-seq BAM files from ENCODE/
Caltech corresponding to two non-strand-specific RNA 75-bp
paired-end experiments in the K562 cell line were downloaded
from the UCSC database. RPKM (reads per kb per million
mapped reads) were calculated using Cufflinks v2.0.2, and the
mean of the two replicates were used for forward analysis. Only
genes with Myc, Sin3a, or both in their promoter (defined as
above) and with expression levels of 5 RPKM were selected.
Accumulated frequencies were normalized against the number
of expressed genes in each case and plotted against the RPKM.
RESULTS
Sin3b Identified as a Myc Interactor in a Yeast Two-hybrid
Assay—To identify new Myc interactors, the ORF of human
Myc was used as bait in a two-hybrid assay in S. cerevisiae
AH109 strain. The vector pGBKT7-Myc was co-transformed
with a NIH3T3 library based on the pACT2 vector. pGBKT7-
Myc with empty vector did not give positive colonies (Fig. 1A,
left). Also, the co-transformation of pACT2-Myc and pLAM5
(which encodes for lamin C) did not allow growth in restriction
medium (Fig. 1A, right), indicating that the positive clones
obtained in the screening were not artifacts due to fortuitous
interactions. Sixty positive clones (i.e. growing in selective
medium SC AHLW) were detected in our screens. We
focused on one of them, clone M168, which encoded a region of
Sin3b, a transcriptional co-repressor known to interact with
Mxd proteins. The region of clone M168 comprised amino
acids 5–194 of the mouse Sin3b protein (Fig. 1A). This region of
Sin3b encompasses the PAH1 domain (amino acids 30 –100)
and part of the PAH2 domain (amino acids 145–230) (Fig. 1A,
bottom panel). Next, we confirmed this interaction in animal
cells. Expression vectors for tagged Myc and full-length Sin3b
were transfected into HEK293T cells, and the lysates were
immunoprecipitated for Sin3b and Myc using antibodies
against the corresponding tags. The results showed that Myc
was present in the immunoprecipitates for Sin3b (Fig. 1B), and
Sin3b was present in the immunoprecipitates for Myc (Fig. 1C).
The results of the two-hybrid assay indicated a direct interac-
tion between Myc and Sin3b. To confirm this finding, extracts
of HEK293T cells transfected with Sin3b were incubated with
FIGURE 2. Interaction between endogenous Myc and Sin3b. A, endogenous Myc and Sin3b interact in the nuclei of human cells. Lysates from K562/S cells
were immunoprecipitated (IP) with anti-Myc antibodies as indicated, and the levels of Sin3b and Myc were analyzed by immunoblotting. IgG HC, rabbit heavy
chain IgG cross-reacting with anti-murine IgGs. B, immunofluorescence of the indicated proteins in K562/S cells untreated and treated with TPA to decrease
Myc expression. Confocal images of the nuclei of representative cells are shown. In the bottom panel (Myc  Sin3b), the yellow color indicates co-localization
of Sin3b and Myc in the nucleus. C, immunoblot of Myc, Sin3b, Mxd1, and Max proteins in K562/S cells untreated and treated with 10 nM TPA for 24 h. D,
detection of Myc-Sin3b interaction by in situ PLA. A representative nucleus is shown for each pair of interactive proteins assayed. Nuclei were counterstained
with DAPI. The anti-Sin3b and anti-Myc antibodies used were rabbit A20 and mouse C33 antibodies, respectively (Table 1). E, quantification of isPLA signals. At
least 200 nuclei were scored for each pair of assayed proteins. 100% means that the positive signal covered the entire nucleus.
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full-length Myc-GST recombinant protein purified from bac-
teria. After pull-down, Sin3b was readily detected as bound to
Myc (Fig. 1D). Finally, we assayed the binding between recom-
binant Myc and Sin3b proteins. The results showed that a
fusion protein consisting of GST and the three first PAH
domains of Sin3b (termed GST-NSin3b) could pull down Myc
protein (Fig. 1E). The GST protein, used as a control, did not
bind Myc in this experiment. These results support the hypoth-
esis of a direct interaction between Myc and Sin3b.
Interaction between Endogenous Myc and Sin3b Proteins—
We next asked whether endogenous Myc and Sin3b interacted
in the cells. We selected for this purpose human myeloid leu-
kemia cells K562, as they are known to express high levels of
Myc and also high levels of endogenous Sin3b. We conducted
immunoprecipitation with anti-Myc, and Sin3b was detected in
the Myc immunoprecipitates (Fig. 2A). The results showed that
at least a fraction of endogenous Myc and Sin3b proteins inter-
acted in K562 cells. Most of Myc and Sin3b localized in the cell
nuclei, and the expectation would be that the Myc-Sin3b com-
plexes would also be nuclear. By immunofluorescence we
showed that Myc and Sin3b co-localized in the cell nuclei of
K562/S cells (an adherent K562 subline) (Fig. 2B). The total
expression of Myc and Sin3b was assessed by immunoblot (Fig.
2C). As a control, we used cells treated for 24 h with 20 nM TPA,
a treatment that reduces Myc expression (45). To confirm the
interaction between endogenous Myc and Sin3b and the cell
compartment in which the interaction took place, we per-
formed isPLA in K562/S cells. This technique allows the visu-
alization of interactions of endogenous proteins and their local-
ization in the cell, avoiding possible artifacts caused by protein
overexpression or protein misfolding as in the FRET technique
(43, 46). We used rabbit anti-Sin3b and mouse anti-Myc pri-
mary antibodies and secondary antibodies conjugated to probe
oligonucleotides. The bound secondary antibodies guided the
FIGURE 3. Myc region involved in Sin3b interaction. A, upper panel, the Myc deletion constructs used. Lower panel, HEK293T cells were transfected with the
indicated construct and Sin3b-HA. Twenty-four hours later, Myc was immunoprecipitated (IP) using anti-FLAG antibody, and the presence of Sin3b in the
precipitates was assayed by immunoblotting. B, Max is not required for Myc-Sin3b interaction. Left panel, UR61 cells were transfected with vectors for Myc-FLAG
and Sin3b-HA, and after transfection, the lysates were immunoprecipitated with anti-FLAG. The presence of Myc and Sin3b in the immunoprecipitates was
analyzed by immunoblotting with anti-FLAG and anti-HA antibodies, respectively. Immunoprecipitations with IgG were conducted as a negative control. Right
panel, endogenous Myc of UR61 cells was immunoprecipitated with anti-Myc antibodies, and the levels of Sin3b and Myc in the immunoprecipitates were
analyzed by immunoblotting. IgG HC, rabbit heavy chain IgG cross-reacting with anti-murine IgGs.
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formation of circular DNA strands when bound in close prox-
imity. The circular DNA strands in turn served as templates for
localized rolling-circle amplification, allowing the visualization
of Myc-Sin3b complexes. We conducted isPLA in growing cells
and in TPA-treated cells. As positive controls we also tested the
interaction between Myc and Max and between Mxd1 and
Sin3b. The expression of Mxd1 in these cells was assessed by
immunoblotting (Fig. 2C). The results showed a clear positive
isPLA signal in the nuclei of the cells. This signal was dramati-
cally reduced in those cells in which Myc levels were abated by
TPA treatment (Fig. 2D). Quantification of the corresponding
signals is shown in Fig. 2E. Consistent with the lower Myc
expression in TPA-treated cells, the level of interaction was also
reduced in these cells. In contrast, the signal of Sin3b-Mxd1 was
consistent with the lack of effect of TPA on Sin3b and Max
levels (Fig. 2, B and C). Overall, the results demonstrated that
endogenous Myc and Sin3b interact in the cell nuclei.
Myc Interacts with Sin3b through Myc Box III—The data
from the yeast two-hybrid assay suggested that Sin3b interacted
with Myc through the first two PAH domains (Fig. 1). To dis-
sect the Myc regions involved in the interaction with Sin3b, we
transfected HEK293T cells with Sin3b and a collection of six
Myc mutants (Fig. 3A, upper panel) and conducted co-immu-
noprecipitations to identify the mutants with bound Sin3b. The
results (Fig. 3A, lower panel) showed that the mutants
MycD157–262 and MycD186 –203 did not bind to Sin3b.
Therefore, we concluded that the region comprising amino
acids 186 –203 was required for the interaction. The mutant
lacking the helix-loop-helix/leucine zipper domain, which is
responsible for the interaction with Max, was able to interact
with Sin3b. To confirm that the interaction was independent of
Max, we conducted the immunoprecipitation in PC12-derived
UR61 cells, which lack a functional Max gene, expressing
instead a truncated and rearranged Max (39, 47). Expression
vectors for tagged Myc and Sin3b were transfected into UR61
cells, and after the immunoprecipitation of the protein lysate
with anti-FLAG (for Myc) and anti-HA (for Sin3b), the pres-
ence of both proteins in the immunoprecipitated fraction was
investigated by immunoblotting. The results showed that Myc
and Sin3b co-immunoprecipitate in UR61 cells (Fig. 3B).
Endogenous Myc and Sin3b of UR61 cells also co-immunopre-
cipitated (Fig. 3B, right panel). Overall, these results confirmed
that Max was not required for Myc to interact with Sin3b.
Sin3b Antagonizes Myc Transactivation Activity—Sin3b
functions as a transcriptional repressor through a mechanism
involving recruitment of HDACs. Therefore, we tested whether
Sin3b modified the transcriptional activity of Myc. We per-
formed luciferase assays using a reporter carrying a minimal
promoter with four Myc-binding E-boxes upstream of the lucif-
erase gene. As a control reporter, we used the same Myc-re-
sponsive reporter construct but with mutated E-boxes, which
are unable to bind to Myc-Max. The results showed that co-ex-
pression of Sin3b clearly reduced transactivation of the pro-
moter by Myc in HEK293T cells (Fig. 4A).
We then studied the effect of Sin3b on the transactivation
elicited by wild-type Myc and the Myc mutant MycD186 –203,
which is unable to bind to Sin3b. The results showed that
although the MycD186 –203 mutant activated the luciferase
reporter to a similar extent as wild-type Myc, Sin3b was
unable to impair transactivation by the Myc mutant (Fig.
4B), suggesting that direct interaction was required for the
repression of Myc transcriptional activity by Sin3b. The
results described above indicated that the Myc mutant lack-
ing the Max interaction domain could still bind to Sin3b. To
investigate whether Max was required for Sin3b-induced
impairment of Myc transactivation activity, we carried out
luciferase assays in the UR61 cell line. It was reported previ-
ously that Myc activates this reporter construct in the
absence of Max in UR61 cells (39). We showed that Sin3b
FIGURE 4. Sin3b impairs the transactivation activity of Myc. A, HEK293T cells
were transfected with the indicated vectors or empty vector (EV). Twenty-four
hours after transfection, the effect of Sin3b on Myc transcriptional activity was
analyzed by a luciferase assay using a promoter-luciferase construct containing
four Myc-responsive elements (light grey) or mutated Myc elements (black bars).
Data were normalized to the-galactosidase activity. Data are mean valuesS.E.
of eight independent experiments. **, p0.01. B, HEK293T cells were transfected
with the indicated Myc and Sin3b constructs, and luciferase activity was assayed
as in A. Data are mean values  S.E. of six independent experiments. **, p  0.01.
C, UR61 cells were transfected with the indicated vectors, and Myc transcriptional
activity was determined as in A. Data are mean values  S.E. values of six inde-
pendent experiments. *, p  0.05.
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efficiently impaired Myc-dependent transactivation in UR61
cells, i.e. in the absence of Max (Fig. 4C).
Sin3a Also Binds Myc—We then investigated whether Myc
also bound to Sin3a, the other member of the Sin3 family. We
transfected Myc and Sin3a expression vectors into HEK293T
cells, and co-immunoprecipitation assays were carried out as
described above. The results showed that Myc also formed
complexes with Sin3a (Fig. 5A). We compared the effects of
Sin3a and Sin3b on Myc-mediated transactivation. The results
of the luciferase assays indicated that Sin3a and Sin3b were
similarly efficient in reducing the transcriptional activity of
Myc (Fig. 5B). Further, similar to Sin3b, Sin3a showed no effect
on the transcriptional activity of the MycD186 –203 mutant
(Fig. 5C), suggesting that the 186 –203 region of Myc was
responsible not only for Sin3b but also Sin3a binding.
Histone Deacetylase Also Is Recruited by Sin3b-Myc
Complexes—As described in the Introduction, Sin3 proteins are
known transcriptional repressors, and the mechanism of action
involves the recruitment of HDACs to induce a less active chro-
matin conformation. To find out whether the activity of
HDACs was involved in the decrease of the transcriptional
activity of Myc, we first used the HDAC inhibitors TSA and
vorinostat. In the presence of these inhibitors, Sin3b was unable
to repress Myc activity (Fig. 6A). To confirm the involvement of
the HDACs, we asked whether the forced expression of HDACs
enhanced the repressive effect of Sin3b on Myc transcriptional
activity. The cells were co-transfected with Myc, Sin3b,
HDAC1, and HDAC2. We found that co-expression of HDAC1
augmented the repression exerted by Sin3b (Fig. 6B). In view of
these results, we investigated whether HDAC1 was present in
the Myc-Sin3b complexes. Co-immunoprecipitation experi-
FIGURE 5. Sin3a also binds Myc and impairs Myc transcriptional activity.
A, co-immunoprecipitation of Myc and Sin3a in HEK293T cells. The cells were
transfected with vectors for Myc-FLAG and Sin3a-myc, and after transfection
the lysates were immunoprecipitated (IP) with anti-FLAG to detect Myc-
bound proteins. The immunoprecipitates were analyzed by immunoblotting
with anti-FLAG (to detect Myc) and anti-Myc (to detect both Sin3a and Myc)
antibodies. Only the band corresponding to Sin3a-myc is shown. Immuno-
precipitation experiments with IgG were conducted as negative control. B,
HEK293T cells were transfected with the indicated vectors or the empty vec-
tor (EV). Twenty-four hours after transfections the effect of Sin3a on Myc tran-
scriptional activity was analyzed by a luciferase assay using a promoter-lucif-
erase construct containing four Myc-responsive elements. Data were
normalized to the -galactosidase activity. Data are mean values  S.E. of
three independent experiments and were measured in duplicates. C, the
Myc-(186 –203) region is required for Sin3a-mediated repression. HEK293T
cells were transfected with the indicated vectors or empty vector and the
E-box luciferase reporter. 24 h after transfection the Myc transcriptional activ-
ity was analyzed as described in the legend for Fig. 4. Data are mean values 
S.E. of six independent experiments. **, p  0.01.
FIGURE 6. HDAC is recruited to Myc-Sin3b complexes. A, HEK293T cells
were transfected with the indicated vectors or empty vector (EV). Twenty-four
hours after transfection, the cells were treated with 0.3 M TSA or 5 M vori-
nostat for 24 h, and Myc transcriptional activity was determined by a lucifer-
ase assay using the E-box promoter construct. Data are mean values  S.E. of
six independent experiments. **, p  0.01. B, Sin3b is required for HDAC1-
mediated repression. HEK293T cells were transfected with the indicated vec-
tors or empty vector, and Myc transcriptional activity was analyzed as
described in the legend for Fig. 4. C, left panel, co-immunoprecipitation of Myc
and HDAC1 in HEK293T cells. The cells were transfected with vectors for Myc-
FLAG and Sin3b-HA, and after transfection, the lysates were immunoprecipi-
tated (IP) with anti-FLAG. The immunoprecipitates were analyzed by immu-
noblotting to detect Myc, Sin3b, and HDAC1. Immunoprecipitation
experiments with IgG were conducted as a negative control (not shown).
Right panel, lysates from K562/S cells were immunoprecipitated with anti-
Sin3b and anti-Myc antibodies as indicated, and the levels of Sin3b, Myc, and
HDAC1 were analyzed by immunoblotting. IgG HC, rabbit heavy chain IgG
cross-reacting with anti-murine IgG.
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ments were performed in HEK293T cells, and the results
showed that HDAC1 was present in the complexes with Sin3b
and Myc (Fig. 6C, left panel). Moreover, endogenous HDAC1
co-immunoprecipitated with both endogenous Myc and Sin3b
in K562/S cells (Fig. 6C, right panel).
Myc and Sin3 Co-localize on Chromatin—As an important
fraction of Myc in the cell nuclei is bound to chromatin, we
asked whether Sin3 can also be found at Myc-bound chromatin
sites. Therefore we employed ChIP assays to analyze Myc-
Sin3b co-localization on some Myc target sites. We used the
P493-6 human lymphoblastoid cell line, which displays condi-
tional Myc expression with the Tet-off system (37) (Fig. 7A).
The ChIP assays, conducted on several E-box-containing pro-
moter regions described previously as binding Myc (48),
showed that Sin3b could also co-localize with Myc on the chro-
matin corresponding to regions of the promoter of the four
genes tested (Fig. 7B). Interestingly we found that both Myc and
Sin3b bound to the promoters regardless of whether the gene
was induced (e.g. CDK4 and NCL) or repressed (e.g. SRD5A1
and HES1) by Myc, indicating that the extent of co-localization
varies among genes but occurs both in Myc-induced (CDK4)
and Myc-repressed genes (SRD5A1) (Fig. 7C). Indeed, in a
majority of the genes tested, the ChIP Sin3b signal did not sig-
nificantly increase even though Myc signal increased. To study
whether Myc and Sin3a/b are in the same complex in the cells,
we performed sequential ChIP (re-ChIP). Chromatin of K562
cells was first immunoprecipitated with anti-Myc antibody and
then with anti-Sin3b. The results showed that Sin3b co-local-
ized with Myc on the E-box-containing promoter region of
CAD and LDHB, two typical Myc target genes (Fig. 7D).
Moreover, the genome-wide pattern of Myc and Sin3a (but
not Sin3b) binding in several human cell lines has been deter-
mined by ChIP-seq by the ENCODE project consortium (data
available at the University of California Santa Cruz browser).
The comparison of Myc and Sin3a binding patterns on K562
cell line revealed that Sin3a is present in 20% of the Myc
binding sites on the genome (Fig. 8A). Mxd proteins may also
recruit Sin3a to the same sites, and thus the actual fraction of
Sin3a bound to Myc-binding regions is unknown. To assess
whether the Myc-Sin3a co-localization on chromatin was
higher in promoters (defined as 1 kb upstream and downstream
from the transcription start site of the genes), we quantified the
binding sites normalized to Mb of genomic DNA. The results
show that this co-occupancy also occurred in promoters,
although the sites with Myc without Sin3a were more frequent
(Fig. 8B). Taken together, the results strongly suggest that a
fraction of Myc bound to chromatin also interacts with Sin3a.
Interestingly, the coincidence of Myc and Sin3a in the proximal
promoters does not correlate with a lower expression with
respect to genes with Myc alone (Fig. 8C).
Sin3b Deacetylates Myc and Promotes Myc Degradation—
The fact that we did not find correlation between the presence
of Sin3a/b and transcriptional repression by Myc in most genes
led us to the hypothesis that the major effect of Sin3-HDAC
binding was not at the level of transcriptional repression. Myc
has been shown to be acetylated, which regulates Myc stability
(49 –52). On the other hand, it has been reported that Sin3a
induces deacetylation of Myc protein resulting in decreased
Myc stability (53). We asked whether this was also the case with
Sin3b. HEK293T cells were transfected with expression vec-
FIGURE 7. Co-localization of Myc and Sin3b in chromatin. A, repression of Myc expression by tetracycline in P493-6 cells. Cells were treated for 24 h with 0.1
g/ml tetracycline (Tet), and the levels of Myc were determined by immunoblot. B, ChIP of Myc and Sin3b on the E-box-containing regions of NCL, CDK4,
SRD5A1, and HES1 genes (39). P493-6 cells were treated with tetracycline for 72 h and then washed, and grown in medium without tetracycline for another 12 h
to induce Myc expression. The data are mean values of five experiments normalized against the values obtained with IgG for each amplicon. C, mRNA
expression of the indicated genes in cells with induced Myc (black bars) versus uninduced cells. Cells were treated as described in B. D, co-occupancy of Myc and
Sin3b on DNA assayed by re-ChIP. ChIP for Myc (left panel) and sequential ChIP for Sin3b of Myc-bound chromatin (right panel) were performed on the
E-box-containing regions of the promoters of CAD and LDHB genes of K562 cells. Data are mean values of two independent experiments.
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tors for Myc, Sin3b, and the acetyltransferase Kat2a (GCN5),
and 24 h after transfection the levels of acetylated Myc were
assessed by immunoblot with anti-acetyl-Lys in the immu-
noprecipitates obtained with anti-Myc. The results showed
that Kat2a expression resulted in Myc acetylation, as
reported previously (53), and that levels of acetylated Myc
dramatically decreased upon the expression of Sin3b (Fig.
9A). Consistently, transient transfection of the Sin3b expres-
sion vector into human leukemia cells (K562 and HEK293T)
resulted in a reduction of Myc protein levels (Fig. 9B). This
reduction was not observed at the Myc mRNA levels, as
shown in Fig. 9C. We also ruled out a lower Myc protein
expression due to reduced proliferation of cells transfected
with Sin3b, as shown by cell counting (not shown) and by the
levels of phospho-histone H3 (Fig. 9B). Next, we evaluated
the effect of Sin3b depletion on Myc levels. The reduction of
Sin3b levels upon transfection of siRNAs in human K562
cells or Rat1a fibroblasts resulted in the up-regulation of
Myc protein (Fig. 9D). We asked whether the deacetylation
of Myc mediated by Sin3b-HDAC modified the stability of
Myc protein. HEK293T cells were co-transfected with Sin3b
and Kat2a expression vectors, and the protein stability was
assayed with cycloheximide treatment. The immunoblot
results showed a faster Myc degradation in Sin3b-expressing
cells (Fig. 9E). Altogether, the data suggest that HDAC1 is
recruited to Myc-Sin3b complexes, which leads to the
deacetylation and subsequent destabilization of Myc.
Low Sin3b Correlates with Breast Cancer Progression—The
expression of Sin3b is reduced in many cancer types and most
clearly in breast cancer (ONCOMINE database and Ref. 54).
Moreover, the meta-analysis of Sin3b mRNA expression in data
sets available in public breast carcinoma database showed that
low Sin3b expression was associated with a decrease in overall
free survival and in distant metastasis-free survival Table 3 and
Fig. 10A). These observations, along with the above results,
prompted us to explore the correlation between Sin3b and Myc
protein levels in breast cancer. We analyzed Sin3b and Myc
expression by immunohistochemistry in 102 infiltrating ductal
breast carcinomas. We observed a lack of expression of Sin3b in
57% of the samples. Interestingly, we detected a strong associ-
ation between low Sin3b expression in the primary tumors and
distant metastasis (Fig. 10B). These observations indicated that
Sin3b expression could be considered as a prognosis marker in
breast cancer. In addition, we found that tumors with high
Sin3b expression showed a tendency to present low Myc pro-
tein levels, although the association was weak (55.8% Myc-low
versus 44.2% Myc-high, p 	 0.06).
DISCUSSION
We have described here a direct interaction between Myc
and the transcriptional corepressor Sin3b. We initially discov-
ered this interaction by yeast two-hybrid screening. Further-
more, Myc and Sin3b co-immunoprecipitated in human
HEK293T and rat UR61 cells upon transfection of expression
vectors. Endogenous Myc and Sin3b also interacted in K562
cells, as shown by co-immunoprecipitation and isPLA. More-
over, we also detected the interaction of Sin3b with purified
recombinant Myc, and we confirmed this interaction using
purified Myc protein and a purified fusion Sin3b protein con-
sisting of GST and the N-terminal region of Sin3b. Interest-
ingly, in a previous report on two-hybrid screen designed to
search Sin3b interacting peptides, two interacting peptides
were found with a sequence similar to Myc Box III (55) (not
shown). Although Sin3a did not appear in our initial two-hybrid
screen, Sin3a also co-immunoprecipitated with Myc in cells
and exerted the same effects on Myc-dependent transcription
as did Sin3b. We also showed that Sin3b and Myc bind to the
same promoter regions. Also, the genome-wide ChIP-seq data
available in the UCSC genome browser reveal that Sin3a and
Myc co-localize in a relevant fraction of chromatin sites. Taken
together, the data strongly argue in favor of a direct interaction
between Myc and Sin3b.
The Sin3b region found in the two-hybrid positive clone cor-
responds to amino acids 5–194, encompassing most of the
FIGURE 8. Genomic-wide analysis of co-localization of Myc and Sin3a on
chromatin of K562 cells. A, binding sites in the genome of K562 cells shared
by Myc, Max, and Sin3a. The black bars indicate the total sites (All Peaks) and
the gray bars the number of sites in the promoter, defined as 1 kb upstream
and downstream of the transcription start site. B, the number of binding sites
of the indicated proteins, normalized to Mb of genomic DNA. Black and gray
bars are as described in A. The inset shows only the peaks in the promoters. C,
correlation between gene expression and binding of Myc and Sin3a to the
sites in promoters of K562 cells. The graph shows the RPKM from the RNA-Seq
data against the percentage of expressed genes normalized for each immu-
noprecipitated protein. The accumulated frequencies were normalized
against the number of expressed genes in each case (shown in parentheses).
The inset represents the fraction of expressed genes of those with Myc or
Sin3a on their promoters.
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PAH1 and PAH2 domains (amino acids 30 –230). Myc muta-
tional analysis showed that the Sin3b-interacting region
includes amino acids 186 –203. This region essentially corre-
sponds to the conserved Myc Box III (56). Interestingly, Max is
not required for Sin3b binding to Myc, and Sin3b impaired Myc
transcriptional activity on E-box-carrying promoters. How-
ever, Sin3b and Sin3a showed no effect on the transactivation
mediated by the Myc mutant lacking the region required for
Sin3 interaction (amino acids 186 –203).
It has been reported that Myc represses some genes through
the recruitment of HDACs and that Myc Box III is required for
this activity (57). We found that the Myc region involved in this
repression was the same region required for Sin3b and Sin3a
TABLE 3
Correlation of Sin3b expression with breast cancer survival and meta-
static capacity
The breast microarray and clinical data were obtained from the International Can-
cer Research database. Several independent data sets of breast carcinoma series
were analyzed. A statistical survival analysis of breast samples was performed using
ROCK and SPSS software. The results corresponding to three studies are shown.
Breast cancer data
set source
Low expression of
Sin3b correlated to
decreased overall
survivala
Low expression of
Sin3b correlated to
decreased distant
metastasis-free
survivala
Van de Vijer et al. (59) 0.026 0.032
Perreard et al. (60) 0.041 0.021
Chin et al. (58) 0.036 0.001
a Log-rank test.
FIGURE 9. Sin3b results in Myc deacetylation and Myc down-regulation. A, HEK293T cells were transfected with Myc-FLAG, Sin3b-HA, and Kat2a expression
vectors or empty vector (EV). Twenty-four hours after transfection, the lysates were immunoprecipitated (IP) with anti-FLAG antibody and analyzed by
immunoblotting with anti-acetyl-lysine antibody. Levels of Myc, Kat2a, Sin3b, and -tubulin (as loading control) in the lysates (Input) were determined by
immunoblotting. B, left panel, K562 cells were transfected with Sin3b expression vector or empty vector, and 48 h later the levels of Sin3b, Myc, phospho-
histone H3 (p-H3) (as a control for proliferation) and actin (as loading control) were determined by immunoblotting using mouse monoclonal antibodies for
Sin3b and rabbit polyclonal antibodies for Myc and actin. Untransfected cells were also included as a control. C, K562 cells were transfected with Sin3b
expression vector or empty vector or transfected with siRNA for Sin3b (si-Sin3b, 1 g) or control scrambled siRNA. Forty-eight h later (for Sin3b expression
vector transfection) or 72 h later (for siRNA-Sin3b) the levels of Myc mRNA were determined by RT-qPCR. The data were normalized to the levels of -actin
mRNA. D, K562 or Rat1aMyc cells were transfected with siRNA for Sin3b or scrambled siRNA as a control. Forty-eight h later, the levels of Sin3b and Myc were
determined by immunoblotting. Actin was used as control for protein loading. E, left panel, HEK29T cells were transfected with Kat2a and Sin3b-HA or its
corresponding empty vector, and 48 h later the cells were treated with cycloheximide (Chx, 60 g/ml) for the indicated periods of time. The levels of Sin3b,
Kat2a, and actin (as loading control) were determined by immunoblotting. A representative immunoblot is shown. Right panel, relative Myc protein levels
determined by densitometry of the immunoblots. Myc signals were normalized to those of actin. Data are mean values  S.E. from three independent
experiments.
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binding. Therefore, we propose that Sin3 mediates the interac-
tion of Myc with HDAC1, although interaction with other pro-
tein deacetylases cannot be ruled out. This proposal is based on
these findings: (a) the co-expression of HDAC and Sin3b
enhanced the repressive effect on E-box-containing reporters;
(b) HDAC inhibitors (e.g. TSA and vorinostat) impaired the
effect of Sin3b on Myc-mediated transcription; and (c) overex-
pression of HDAC alone did not modify Myc transcriptional
activity. Therefore, Sin3b acts as a negative modulator of Myc
transcriptional activity.
Several concomitant mechanisms could explain the repres-
sion of Myc activities by Sin3b. One would be the recruitment
of Mxd protein to the promoter to exert transcriptional repres-
sion. This model is depicted in Fig. 11A. Although this mecha-
FIGURE 10. Correlation of low Sin3b expression with poor survival in breast cancer. A, correlation of Sin3b expression with Overall Free Survival and Distant
Metastases Free Survival in human breast cancer. One data set of breast cancer and Sin3b expression (58) was used to generate Kaplan-Meier plots to show the
correlation of Sin3b expression with overall free survival (left) and distant metastases free survival (right). B, representation of the correlation between Sin3b
immunohistochemical expression and metastasis in invasive ductal breast carcinomas (n, number of tumors analyzed; P, statistical significance). Representa-
tive examples of the immunohistochemical study with and without expression of Sin3b are shown at the right (scale: 
200).
FIGURE 11. Mechanistic models for Sin3b-Myc functional interaction. The three mechanisms are not mutually exclusive. A and B show the already known
activities of Sin3b. An additional mechanism, C, is favored in this study. In this mechanism, Sin3b recruits deacetylases, which would render the Myc protein
more unstable. Other proteins in the Sin3b complex are not shown for simplicity. See “Discussion” for details.
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nism must operate in vivo, by itself it cannot explain our results,
as the D186 –203 Myc mutant did not interact with Sin3b and
yet transactivated an E-box reporter even when Sin3b was co-
expressed. Thus, the increase in Mxd-Sin3b-HDAC complexes
on chromatin was not the main mechanism responsible for the
diminished transcriptional activity of Myc in the presence of
Sin3b.
A second explanation would be that the effect of Sin3b
depends on histone deacetylation in the regulatory region of
Myc-bound genes, leading to transcription repression (sche-
matized in Fig. 11B). However, our ChIP results argue
against this hypothesis as the major mechanism. In human
leukemia cells, we found that both Myc and Sin3b bound to
some promoters regardless of whether the gene was induced
or repressed (Fig. 7), and Sin3b binding at these sites was not
related to histone acetylation marks (48). Also, the combined
analysis of ChIP-seq and RNA-seq data generated by the
ENCODE consortium revealed that in K562 cells, the coin-
cidence of Myc and Sin3a on the proximal promoters did not
correlate with a lower expression with respect to genes with
Myc alone (Fig. 8). Thus, our data do not support a direct role
of Sin3b in transcriptional repression of Myc target genes.
Given that the binding of Myc and Sin3b to chromatin can be
transient, we cannot rule out an effect of Sin3b binding to
Myc that leads to gene repression via histone deacetylation.
Actually, Myc-mediated repression of some genes (e.g.
GADD45 and ID2) in Rat1a cells was impaired by co-trans-
fection of Sin3b siRNA (not shown). However, taken
together, the ChIP data are not consistent with this mecha-
nism being the major one responsible for the decrease in
Myc activity when Sin3b is co-expressed.
A third explanation is that Sin3b leads to reduced Myc
levels. It is reported that Sin3a induces Myc deacetylation
(53), and we have confirmed the same effect for Sin3b.
Although the underlying mechanisms are not clear yet, it has
been reported that acetylation of Myc by acetyltransferases
(e.g. GCN5, Tip60, and p300/CBP) usually results in an
increase in protein stability (49 –53), although Myc deacety-
lation by Sirt1 results in increased stability (52). We showed
that Sin3b decreased Myc levels, whereas Sin3b depletion
augmented Myc levels. The simplest explanation is that
Sin3b interaction contributes to Myc deacetylation leading
to reduced Myc levels, as schematized in Fig. 11C. In agree-
ment with the findings in cultured cells, we also found an
association between high Sin3b and low Myc in human
breast cancer samples (although the data were not statisti-
cally significant). In summary, the data suggest that, at least
in some cell types, Sin3b controls Myc levels through a
mechanism that involves protein deacetylation and destabi-
lization. Further work is required to dissect the underlying
mechanisms. On the other hand, transcriptional repression
by Mxd of Myc target genes can also be mediated by Sin3b.
Thus, Sin3b may reduce Myc activity through two parallel
pathways: the canonical Sin3b-Mxd interaction, resulting in
Myc target gene repression, and the reduction of Myc levels,
as shown in this work. The effect of Sin3b on Myc activity
opens possibilities of therapeutic intervention for Myc-
driven tumors.
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